cardiac rhythm


Also found in: Dictionary, Thesaurus, Legal, Encyclopedia, Wikipedia.
Related to cardiac rhythm: heart rhythm

cardiac rhythm

The predominant electrical activity of the heart. It may be determined by recording an electrocardiogram or by evaluating tracings made by a cardiac monitor.
See: cardiac cycle; electrocardiogram; conduction system of the heart
See also: rhythm
References in periodicals archive ?
The key players in the Global Cardiac Rhythm Management Devices Market are Boston Scientific, Medtronic and St.
Lack of awareness about sudden cardiac arrests and high cost of the devices is expect to hinder the growth of the cardiac rhythm management market.
"It recommends that clinicians 'might' [level C evidence] obtain outpatient cardiac rhythm studies in patients with cryptogenic stroke without known NVAF to identify patients with occult NVAF." He added that the guideline also recommends that monitoring might be needed for prolonged periods of 1 or more weeks rather than for shorter periods, such as 24 hours.
ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary.
When it comes to cardiac rhythm, smartphones can be used to detect arrhythmias such as atrial fibrillation (J.
Jayne, the country's first nurse consultant in cardiac rhythm management, said: "I was delighted to have picked up the award on behalf of our team."
This figure includes over 90 research and development personnel working on a number of high value projects such as the development of next generation cardiovascular products and cardiac rhythm disease management delivery systems.
The first step in analyzing a cardiac rhythm strip is determination of the heart rate.
Cardiac rhythm devices; a case-based approach to management.
is a familiar name in the cardiac rhythm management market.
Sales in its cardiac rhythm management unit, its biggest business, increased 11% to $752 million.
Preliminary Cardiac Rhythm Management sales results, which include implantable cardioverter defibrillator (ICD) and pacemaker products, were approximately $690 million for the third quarter of 2009, a 2 percent increase over the third quarter of 2008.

Full browser ?